logo

[breadcrumb_custom]

Akebia Therapeutics Inc. Inc. (AKBA) Price Performance: A Fundamental Analysis Perspective

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Until today this year the stock’s price performance recorded an increase of 31.45%. However, over the last six months, the performance has been weaker by 45.54%. The price of AKBA increased 3.16% over the last 30 days. And in the last five days, it has fallen by -24.88%.

Akebia Therapeutics Inc. experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $2.48 on 03/28/24, while the lowest price for the same period was registered at $0.49 on 04/05/23.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

52-week price history of AKBA Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Akebia Therapeutics Inc.’s current trading price is -34.27% away from its 52-week high, while its distance from the 52-week low is 232.59%. The stock’s price range during this period has varied between$0.49 and $2.48. The Akebia Therapeutics Inc.’s shares, which operate in the Healthcare, saw a trading volume of around 14.01 million for the day, a figure considerably higher than their average daily volume of 4.16 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Akebia Therapeutics Inc. (AKBA) has experienced a quarterly rise of 27.34% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 341.27M and boasts a workforce of 167 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.4016, with a change in price of +0.6851. Similarly, Akebia Therapeutics Inc. recorded 3,205,607 in trading volume during the last 100 days, posting a change of +72.51%.

AKBA Stock Stochastic Average

As of today, Akebia Therapeutics Inc.’s raw stochastic average for the last 50 days stands at 28.57%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 25.44%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 37.13% and 54.21%, respectively.

On Key

Related Posts